Ferguson Merle's Form 4 filing
Bioforce Nanosciences Holdings, Inc. (BFNH) · filed Sep 2, 2026
- Accession no.
- 0001091818-26-000134
- Filed
- Sep 2, 2026, 4:09 PM ET
- Trade date
- Apr 20-22, 2026
- Filing delay
- 135 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. Open-market sales total $400.5K. It was filed 135 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Ferguson MerleCIK 0001749860 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 20, 2026 | Common Stock; Par Value $0.001 | GGiftAcquired | +20,580,000 | $0.007 | +$144,060 | 22,568,000 | Direct | |
| Apr 20, 2026 | Common Stock; Par Value $0.001 | GGiftAcquired | +4,132,000 | $0.001 | +$4,132 | 26,700,000 | Direct | |
| Apr 22, 2026 | Common Stock; Par Value $0.001 | SSaleDisposed | −26,700,000 | $0.015 | −$400,500 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.